Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party o (Q38866851)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 June 2016
edit
Language Label Description Also known as
English
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party o
scientific article published on 16 June 2016

    Statements

    Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party o (English)
    Oliver Ottmann
    Frederic Baron
    Jan J Cornelissen
    Jordi Esteve
    Norbert-Claude Gorin
    Christoph Schmid
    16 June 2016
    2941-2951

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit